Search

everythinglearnresearchcommunity

for

Search:↓

A misdiagnosed case of HAIR-AN syndrome led to unnecessary surgeries and highlighted the importance of correct diagnosis and treatment.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Ovarian Leydig cell tumors are hard to diagnose with just advanced imaging; expert ultrasound and clinical evaluation are essential.

PCOS is linked to low-grade chronic inflammation.

A woman's hair loss was caused by her husband's testosterone gel and a diabetic man's nail disease led to bone infection, both treated successfully.

Early diagnosis and treatment of PCOS can prevent complications and improve symptoms.

The woman's rare combination of diseases suggests an unknown factor may predispose individuals to multiple endocrine diseases.

The study concludes that Twenty-nail dystrophy is more common in boys among children and in women among adults, with varying response to treatment.

Patients with graft-versus-host disease often have nail changes related to the nail matrix, with severity not linked to skin condition.

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Estrogen therapy can reduce skin aging but has cancer risks.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Pregnant women often experience skin and hair changes, with over half getting stretch marks and pigment changes, and should be cautious with cosmetic procedures due to potential risks.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.